Digital & Innovation
Organon and J&J digital leaders explore emerging trends and dynamics shaping 2022 at Digital Acceleration Roundtable

Digital & Innovation: The COVID-19 pandemic has accelerated the adoption of digital transformation in the pharma and medtech sectors. Organisations are investing in digital expertise to understand the gaps and determine the right digital strategies and investment required in meeting their stakeholder needs.
Geoff Quattromani, Digital Transformation Manager at Johnson & Johnson Medical and Sally Dunstan, Customer Experience and Digital Healthcare Marketing at Organon ANZ joined Health Industry Hub Founder Rozalina Sarkezians and co-host Peter Stephenson from West 53rd St Digital for the fourth Digital Acceleration Roundtable to explore the emerging new digital trends impacting industry this year and the key digital dynamics shaping 2022.
The panellists also discussed the critical success factors for omnichannel marketing as a strategic priority, the major opportunities to enhance customer engagement, and the role of data and artificial intelligence (AI) in delivering smarter, more efficient customer engagement models.
In reflecting on the emerging new digital trends that will be impacting the medtech and pharma industries, Geoff Quattromani said “QR codes, virtual and augmented reality have been around for many years but the real world really got to start using and experiencing them through the pandemic. At the moment, it might just be to check into a venue to say that you’re there and comply with COVID rules, but why not when I pick up a garment off the shelf that instead of having that long tag, it just has a QR code where I can see what was in the garment, but actually where it was made and a story about the product. QR codes will change how we experience things in 2022.”
Sally Dunstan added “I’ve really enjoyed watching the rise of investment in the femtech space as a bit of a trend. We’re going to see huge innovations in that space over the next couple of years. The way in which women manage their healthcare needs, where they manage them and the requirements around that in the tech space is really exciting. It can be hugely impactful on women and their families and have a positive social impact.”
Geoff commented “It wasn’t until we were sent home to start living and working from home that we realised we could use these technologies [virtual reality and augmented reality] for different purposes. Virtual reality has been used a lot at J&J to reconnect people or to take people to places where you have shared experiences together. Whether it’s for training purposes or sales purposes, I think we’re going to see those types of technologies lift dramatically in 2022 because we need to think of different ways to engage one another in digital ways.”
You may also like to explore Key trends transforming industry workforce and the recruitment ecosystem in 2022
News & Trends - Biotechnology

CSL reshapes R&D while bracing for U.S. tariffs
Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]
MoreNews & Trends - MedTech & Diagnostics

Australia joins Medtronic trial in fight against resistant hypertension
Medtronic has launched an international clinical trial across Australia, the United States, and Europe to evaluate the feasibility of multi-organ […]
MoreNews & Trends - MedTech & Diagnostics

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban
Medibank has become the first Australian health insurer to pay towards pharmacogenetic testing (PGx) for eligible customers on Extras cover. […]
MoreNews & Trends - Pharmaceuticals

Global pledge shifts visibility and action for patients with advanced breast cancer
Three breast cancer organisations have united internationally to demand that people living with metastatic breast cancer (MBC) are no longer […]
More